Treatment of Recurrent Clostridium Difficile Infection With RBX7455

NCT02981316 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Clostridium Difficile Infection

Interventions

BIOLOGICAL: RBX7455

Sponsor

Mayo Clinic

Collaborators

[object Object]